Inoviv
ActiveLC-MS biomarker panels for drug developers.
What it does
Inoviv delivers custom, multiplexed LC-MS proteomics panels with absolute quantification and end-to-end support for biomarker discovery and validation. These workflows yield high reproducibility and accuracy—helping pharmaceutical teams accelerate development and reduce risk in clinical programs.
Its site says now · captured 2026-08-23
Home - Inoviv
Multiplexed & quantitative LC-MS proteomics with end-to-end support for drug discovery & development using rapid, robust biomarker analysis